David Matthew Nathan MD
Diabetes, Lipid Metabolism
Professor of Medicine, Massachusetts General Hospital
Join to View Full Profile
50 Staniford St3rd Floor S50 3Boston, MA 02114
Phone+1 617-726-2875
Fax+1 617-726-6781
Dr. Nathan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1978 - 1980
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1975 - 1978
Icahn School of Medicine at Mount SinaiClass of 1975
Certifications & Licensure
MA State Medical License 1978 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- Boston Magazine Castle Connolly, 2010, 2012
- Elected Member The American Society for Clinical Investigation, 1994
- Join now to see all
Clinical Trials
- Diabetes Prevention Program Outcomes Study Start of enrollment: 2002 Sep 01
- Epidemiology of Diabetes Interventions and Complications (EDIC) Start of enrollment: 1994 Apr 01
- Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk Start of enrollment: 2007 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Multivitamins After Myocardial Infarction in Patients With Diabetes: A Randomized Clinical Trial.Francisco Ujueta, Gervasio A Lamas, Kevin J Anstrom, Ana Navas-Acien, Robin Boineau
JAMA Internal Medicine. 2025-03-03 - 2 citationsRelationship Between Average Glucose Levels and HbA1c Differs Across Racial Groups: A Substudy of the GRADE Randomized Trial.David M Nathan, William H Herman, Mary E Larkin, Heidi Krause-Steinrauf, Hiba Abou Assi
Diabetes Care. 2024-12-01 - 4 citationsEdetate Disodium-Based Chelation for Patients With a Previous Myocardial Infarction and Diabetes: TACT2 Randomized Clinical Trial.Gervasio A Lamas, Kevin J Anstrom, Ana Navas-Acien, Robin Boineau, Hayley Nemeth
JAMA. 2024-09-10
Journal Articles
- Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of DiabetesVivian Fonseca, David M Nathan, Jonathan Newman, The Journal of Clinical Endocrinology and Metabolism
Lectures
- 2nd Annual Diabetes Symposium: New Advances and InnovationsJefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania - 10/11/2013
- 2nd Annual Diabetes Symposium: New Advances and InnovationsJefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania - 10/11/2013
- 1st Annual Diabetes Symposium: New Advances and InnovationsJefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania - 9/28/2012
- Join now to see all
Press Mentions
As RFK Jr. Champions Chronic Disease Prevention, Key Research Is CutApril 7th, 2025- The Tragic Termination of the Diabetes Prevention Program Outcomes StudyApril 1st, 2025
- GLP-1 Have Real-World Benefits and Risks in Large Scale VA StudyJanuary 27th, 2025
- Join now to see all
Grant Support
- Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD ProjectCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2027
- Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD ProjectCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2027
- Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD ProjectCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2027
- Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD ProjectCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2027
- Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) StudyGEORGE WASHINGTON UNIVERSITY2012–2025
- Diabetes Prevention Program Outcome Study - Phase 2National Institute Of Diabetes And Digestive And Kidney Diseases2009–2012
- Glycemic Reduction Approaches For Treating Diabetes: An Effectiveness StudyNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- Action For Health In Diabetes (Look Ahead)National Institute Of Diabetes And Digestive And Kidney Diseases2006–2011
- Comparison Of Lantus And NPH Insulin In The DAWN PhenomenonNational Center For Research Resources2008
- Clinical Trial: TodayNational Center For Research Resources2008
- Clinical Trial: Diabetes Prevention Program Outcomes Study (DPPOS)National Center For Research Resources2008
- Treatment Options For Type 2 Diabetes In Adolescents And Youth (TODAY)National Center For Research Resources2005–2008
- Look Ahead: Action For Health In DiabetesNational Center For Research Resources2004–2008
- Post-Dpp Followup StudyNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2008
- TodayNational Center For Research Resources2005–2007
- Assessing Energy Needs Of Overweight And Obese Individuals: A Comparison Of MENational Center For Research Resources2005–2007
- Diabetes Prevention Program Outcomes Study (DPPOS)National Center For Research Resources2004–2007
- Partners Roche Type 2 Diabetes ProjectNational Center For Research Resources2004–2005
- SHOW ProjectNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2005
- Diabetes Prevention Program (DPP)National Center For Research Resources2004
- Clinical Center For Look Ahead: Health In DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2002
- Epidemiology Of Diabetes Intervention &Complications (EDIC)National Center For Research Resources1999–2002
- Administration Of GLP 1 By Subcutaneous Delivery--Determination Of DoseNational Center For Research Resources1999–2002
- Diabetes Prevention ProgramNational Center For Research Resources1997–2002
- Diabetes Prevention Program (Ddp-2)National Institute Of Diabetes And Digestive And Kidney Diseases1996–2002
- Diabetes Prevention PROGRAM: Screening STEP 2National Center For Research Resources2000
- GLP-1 By Continous Subcutaneous Delivery--Determination Of DoseNational Center For Research Resources1999
- Insulin Infusion In Type 1 Diabetes Using Implantable PUMPNational Center For Research Resources1998–1999
- Epidemiology Of Diabetes Intervention And ComplicationsNational Center For Research Resources1996–1999
- Investigation Of GLP I, 7-37 (INSULINOTROPIN) In Human SubjectsNational Center For Research Resources1997
- GRF Determination For The Diabetes Control And Complications TrialNational Center For Research Resources1996
- Diabetes Control And Complications TrialNational Center For Research Resources1996
- Primary Prevention Trial (Dpt-2)National Institute Of Diabetes And Digestive And Kidney Diseases1994–1995
- Diabetes Control And Complications TrialNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1994
- Diabetes Control &Complications Trial (DCCT)National Institute Of Diabetes And Digestive And Kidney Diseases1986
- Diabetes Control And Complications Trial (DCCT)Nat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
